Carregant...
Eplerenone: A New Aldosterone Receptor Antagonist—Are the FDA's Restrictions Appropriate?
Eplerenone is a new aldosterone receptor antagonist that will be used in the treatment of hypertension. Like spironolactone, it is a compound that can be associated with the development of hyperkalemia. Therefore, the same prescription considerations that are applied to spironolactone should be dire...
Guardat en:
| Publicat a: | J Clin Hypertens (Greenwich) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Le Jacq Communications, Inc.
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099290/ https://ncbi.nlm.nih.gov/pubmed/12461313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2002.01510.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|